Tuesday, November 17, 2026

MICIN, a startup developing online medical services, and Keio University begin research on severity assessment

MICIN and Keio University Tonomachi Advanced Research and Education Collaboration Square will launch a clinical study to examine the reliability of severity assessment using online medical care for children with neurodevelopmental disorders (attention-deficit/hyperactivity disorder and autistic spectrum disorder) and their parents, with a view to utilizing and introducing digital tools in medical care in Japan. The main objective of the study is to verify the equivalence of remote and face-to-face assessments in the target disorders.

About Neurodevelopmental Disorders

According to a survey published by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in 2012, children with suspected neurodevelopmental disorders such as ADHD (Attention Deficit Hyperactivity Disorder) and ASD (Autism Spectrum Disorder) The percentage of children with neurodevelopmental disorders such as ADHD (Attention Deficit Hyperactivity Disorder) and ASD (Autism Spectrum Disorder) is 6.5%. Patients with neurodevelopmental disorders are prone to various emotional and behavioral problems during adolescence and young adulthood, and early detection and intervention are needed to prevent secondary disorders and to broaden the scope of future social participation.

Challenges in Diagnosing Neurodevelopmental Disorders

The number of child psychiatry specialists and evaluators in the country has been shown to be overwhelmingly inadequate, with the following challenges

  • Long period of time to consult a specialist and to be diagnosed. (It is especially difficult to receive appropriate medical care on remote islands or in areas where there are no specialized medical institutions.)
  • There are limitations in collecting multifaceted information, and the absolute number of appropriately trained evaluators is insufficient throughout the country. As a result, they are forced to rely on simplified evaluation scales, which can easily lead to variations in severity assessment and diagnosis.
  • Many children with neurodevelopmental disorders are withdrawn and have difficulty managing their time, so continuous attendance is not easy.

In Europe and the United States, remote evaluations are already being promoted in various medical fields, and videoconferencing is also used in psychiatry, but there are very few precedents for this in Japan.

Outline and Purpose of this Study

This study will be conducted by Dr. Taishiro Kishimoto, a full-time lecturer in the Department of Psychiatry and Neuroscience at Keio University School of Medicine, who is conducting research in the field of psychiatry using online medical services in Japan to introduce remote diagnosis and evaluation as a solution to these issues.

In order to demonstrate the usefulness of remote assessment in Japan, this study aims to conduct one remote and one face-to-face assessment by a physician or clinical psychologist with children with ASD and ADHD and their parents, and to verify whether the remote assessment is equivalent to the face-to-face assessment and whether the remote assessment is acceptable to the subjects. The purpose is to verify whether the remote evaluation is equivalent to the face-to-face evaluation and whether the remote evaluation is acceptable to the subject. In the future, we aim to improve the accessibility of medical care in the field of neurodevelopmental disorders by homogenizing diagnostic results through the implementation of central evaluation by professional evaluators in Japan.

This research was conducted under the "Program on Open Innovation Platform with Enterprises, Research Institute and Academia (OPERA)" of the Japan Science and Technology Agency (JST). The research area "Creation of life innovation by PeOPLe, a platform for openly utilizing all kinds of information based on people" (Area Representative: Hiroaki Miyata, Professor, Department of Medical Policy and Management, Faculty of Medicine, Keio University; Leader: Tonomachi Advanced Research and Education Collaboration Square), in which Keio University is the lead institution in the "Program on Open Innovation Platform with Enterprises, Research Institute and Academia (OPERA)" of the Japan Science and Technology Agency (JST), is being conducted by the JST and MIC. The project is supported by JST and MICIN within the framework of "Creating Life Innovations with PeOPLe," an infrastructure for medical policy and management, Faculty of Medicine, Keio University.
Also participating in the examination will be the Shimada Rehabilitation Center of the Japan Society for Mentally and Physically Handicapped Children (located in Tama City, Tokyo) and the Tokyo Metropolitan Children's General Medical Center (located in Fuchu City, Tokyo).

In this study, MICIN will provide the online medical treatment system "CURON" for the remote severity assessment performed in the study. Although the online medical examination system is not a "medical device" for diagnosis or treatment, the quality of communication affects the accuracy of the evaluation, and is also important from the perspective of preventing information leakage since it handles medical information. Cron implements the confidentiality, network security, and unauthorized access measures that are essential for the proper implementation of online medical services, and is compliant with the three ministries and three guidelines already in use in the medical field.

About Cron Online Medical Service

Cron" is a service that completes everything online, from making appointments to medical interviews, consultations, payments, and delivery of medications and prescriptions. The service is supported by the fact that the cost burden on medical institutions for installation and operation is zero, and that doctors and patients can share data such as blood glucose levels and blood pressure.

Kron's service introduction site:.https://curon.co

About MICIN Corporation

MICIN is a company founded in 2015 with an application business that handles the online medical treatment service "CURON". In addition to being Japan's leading company in online medical services, MICIN is also developing various services for the healthcare field, including a data solution business that uses AI to analyze and utilize medical data, and a digital solution business (MiROHA) for clinical development of pharmaceuticals, in order to achieve its VISION of "a world where all people can live and die with dignity and satisfaction. The company is developing various services for the healthcare field, including a data solution business that analyzes and utilizes AI for medical data, and a digital solution business for clinical development of pharmaceuticals (MiROHA).

As for MICIN's future development, the knowledge gained from this study in assessing severity of illness using the video call function will be utilized in MICIN's "MiROHA" digital solution for clinical development. MICIN plans to deepen its support for scientific evidence building in Japan by providing an environment in which various verifications using the video call function can be conducted in the areas of clinical trials and research.

name of companyMICIN Corporation
EstablishmentNovember 26, 2015
Location〒100-0004
13F, Nihon Bldg., 2-6-2 Otemachi, Chiyoda-ku, Tokyo
representativeName of Representative Seigo Hara, Representative Director
Business OverviewApplication business for medical institutions such as online medical services
Data solution business that analyzes and utilizes medical data with AI, etc.
Digital solution business for clinical development of pharmaceutical products
uniform resouce locatorhttps://micin.jp/

PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。